News
Bioiberica participated in the Barcelona edition of BIO-Europe on 8 to 10 March 2010. It will also participate in PharmaVenue on 17-18 May in Madrid.
Bioiberica has followed a vertical integration strategy in the last three years towards the development and sale of finished products. All products undergo scientific and clinical development and have their own marketing strategy to support sales in each country.
Bioiberica Farma, the Spanish division of Bioiberica, has received approval for the combination of chondroitin and glucosamine in Spain. This is the first authorization of its kind in Europe.
Bioiberica is going to held during 2010 in the three most important international conferences on diseases of the musculoskeletal system: those organized by EULAR, OARSI and ACR
In 2009 Bioiberica will have participated in the 3 most important international rheumatology conferences, as well as several scientific conferences on sports medicine and nutrition: